• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia-Case Reports and Discussion.低剂量氯氮平强化抗精神病药物治疗难治性精神分裂症——病例报告与讨论
Case Rep Psychiatry. 2021 Jun 19;2021:5525398. doi: 10.1155/2021/5525398. eCollection 2021.
2
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.氨磺必利增效氯氮平治疗精神分裂症无效患者(AMICUS):一项双盲、安慰剂对照、随机临床试验,评估临床疗效和成本效益。
Health Technol Assess. 2017 Sep;21(49):1-56. doi: 10.3310/hta21490.
3
[Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].[与代谢增加及氟伏沙明获益相关的氯氮平难治性精神分裂症:4例报告]
Encephale. 2007 Oct;33(5):811-8. doi: 10.1016/j.encep.2007.01.005.
4
Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.氯氮平联合棕榈酸帕利哌酮治疗难治性精神分裂症及其他精神病性障碍:一项为期 6 个月的回顾性镜像研究。
Eur Psychiatry. 2020 Jul 16;63(1):e71. doi: 10.1192/j.eurpsy.2020.72.
5
Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.氯氮平联合氨磺必利治疗:英国一家高度戒备医院中难治性暴力型精神分裂症患者的有效治疗策略
CNS Spectr. 2014 Oct;19(5):403-10. doi: 10.1017/S1092852913000874. Epub 2013 Nov 28.
6
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
7
Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.米诺环素联合氯氮平在难治性精神分裂症治疗中的潜在应用。
J Psychopharmacol. 2014 Jul;28(7):707-8. doi: 10.1177/0269881114527358. Epub 2014 Mar 19.
8
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.新西兰精神分裂症患者氯氮平处方的治疗途径与模式
Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.
9
Augmentation strategies in clozapine-resistant schizophrenia.氯氮平抵抗性精神分裂症的增效策略
CNS Drugs. 2005;19(10):843-72. doi: 10.2165/00023210-200519100-00004.
10
Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.阿立哌唑增强氯氮平治疗难治性精神分裂症的临床观察
Clin Drug Investig. 2006;26(3):117-24. doi: 10.2165/00044011-200626030-00001.

本文引用的文献

1
Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.氯氮平联合治疗与增效策略在精神分裂症患者中的应用——精神病治疗反应和抵抗(TRRIP)工作组的国际专家调查建议。
Schizophr Bull. 2020 Dec 1;46(6):1459-1470. doi: 10.1093/schbul/sbaa060.
2
Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality.精神分裂症的早期检测与预防干预:从幻想走向现实。
Am J Psychiatry. 2019 Oct 1;176(10):794-810. doi: 10.1176/appi.ajp.2019.19080865.
3
Barriers to using clozapine in treatment-resistant schizophrenia: systematic review.氯氮平用于难治性精神分裂症治疗的障碍:系统评价
BJPsych Bull. 2019 Feb;43(1):8-16. doi: 10.1192/bjb.2018.67. Epub 2018 Sep 28.
4
Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis.氯氮平难治性精神分裂症的增效策略:系统评价和荟萃分析。
Aust N Z J Psychiatry. 2018 Aug;52(8):751-767. doi: 10.1177/0004867418772351. Epub 2018 May 6.
5
[Efficacy of low-Dose Aripiprazole to Treat Clozapine-Associated Tardive Dystonia in a Patient with Schizophrenia].[低剂量阿立哌唑治疗精神分裂症患者氯氮平相关迟发性肌张力障碍的疗效]
Turk Psikiyatri Derg. 2017 Fall;28(3):208-211.
6
Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis.氯氮平治疗难治性精神分裂症的反应率:系统评价和荟萃分析的数据。
Can J Psychiatry. 2017 Nov;62(11):772-777. doi: 10.1177/0706743717718167. Epub 2017 Jun 28.
7
Low-dose Clozapine-induced Seizure: A Case Report.低剂量氯氮平诱发癫痫发作:一例报告
Clin Psychopharmacol Neurosci. 2017 May 31;15(2):190-193. doi: 10.9758/cpn.2017.15.2.190.
8
Early Intervention in Schizophrenia: A Literature Review.精神分裂症的早期干预:文献综述
Arch Psychiatr Nurs. 2016 Dec;30(6):774-781. doi: 10.1016/j.apnu.2016.02.009. Epub 2016 Feb 23.
9
A Case of Resistant Schizophrenia Successfully Treated With Clozapine/Long-acting Injectable Aripiprazole Combination.一例使用氯氮平/长效注射用阿立哌唑联合治疗成功的难治性精神分裂症病例。
Clin Neuropharmacol. 2016 Nov/Dec;39(6):322-324. doi: 10.1097/WNF.0000000000000191.
10
Treatment-Resistant Schizophrenia.难治性精神分裂症
Psychiatr Clin North Am. 2016 Jun;39(2):239-65. doi: 10.1016/j.psc.2016.01.006. Epub 2016 Mar 30.

低剂量氯氮平强化抗精神病药物治疗难治性精神分裂症——病例报告与讨论

Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia-Case Reports and Discussion.

作者信息

Harrison Zoe, Haeney Owen, Brereton William

机构信息

University of Adelaide, Faculty of Health and Medical Sciences, 4 North Terrace, Adelaide South Australia 5000, Australia.

Forensic Mental Health Service/Northern Adelaide Local Health Network, James Nash House, 140 Hilltop Drive, Oakden, Adelaide South Australia 5086, Australia.

出版信息

Case Rep Psychiatry. 2021 Jun 19;2021:5525398. doi: 10.1155/2021/5525398. eCollection 2021.

DOI:10.1155/2021/5525398
PMID:34239749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8235956/
Abstract

Treatment resistance in schizophrenia is often encountered in clinical practice, with clozapine usually recommended as the appropriate therapy. However, where clozapine proves ineffective or cannot be tolerated due to side effects, treatment options are limited. In patients within forensic mental health services, residual symptomatology often presents a barrier to discharge and can have lasting effects on prospects for rehabilitation as well as risk to self and others. This paper presents a review of the relevant literature and three cases of a novel approach, utilising clozapine in doses usually considered subtherapeutic, in combination with the primary antipsychotic treatment. In all three patients, it improved clinical efficacy as well as tolerability, resulting in improvement that allowed discharge from the forensic hospital.

摘要

精神分裂症的治疗抵抗在临床实践中经常遇到,通常推荐氯氮平作为合适的治疗方法。然而,当氯氮平被证明无效或因副作用无法耐受时,治疗选择就很有限。在法医精神卫生服务机构的患者中,残留症状往往成为出院的障碍,并且可能对康复前景以及对自身和他人的风险产生持久影响。本文综述了相关文献,并介绍了三例采用新方法的病例,即使用通常被认为低于治疗剂量的氯氮平,并与主要抗精神病药物治疗联合使用。在所有三名患者中,这种方法提高了临床疗效和耐受性,使患者得以改善并从法医医院出院。